Safety and efficacy of transcatheter aortic valve replacement through transcarotid approach for patients with severe aortic valve stenosis
10.3760/cma.j.issn.0253-3758.2018.03.006
- VernacularTitle: 经颈动脉途径行经导管主动脉瓣置换术治疗重度主动脉瓣狭窄的安全性和有效性
- Author:
Wenzhi PAN
1
;
Daxin ZHOU
;
Xiaochun ZHANG
;
Lei ZHANG
;
Lai WEI
;
Junbo GE
Author Information
1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
- Publication Type:Clinical Trail
- Keywords:
Aortic valve stenosis;
Treatment outcome;
Transcatheter aortic valve replacement
- From:
Chinese Journal of Cardiology
2018;46(3):198-202
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the safety and efficacy of transcatheter aortic valve replacement(TAVR) through transcarotid approach for patients with severe aortic valve stenosis.
Methods:The clinical data of 9 symptomatic severe aortic valve stenosis patients who had high or prohibitive risk for surgery and not suitable for TAVR through femoral artery access,and thus received TAVR through transcarotid approach in our hospital from November 2015 to February 2017 were retrospectively analyzed.The patients were followed up to observe the safety and efficacy of the procedure.
Results:There were 4 male and 5 female patients in this cohort, and age was (75.7±8.7) years old. The Society of Thoracic Surgery (STS) scores were (7.9±1.6)%. All patients were treated by left carotid artery approach. One patient experienced valve dislodgement during the procedure and received surgery, and TAVR procedure was successful in the rest 8 patients. Two patients were implanted with permanent pacemaker because of third degree atrioventricular block during the procedure.One patient had cardiac arrest during the procedure and recovered after external chest compression.One patient developed severe carotid stenosis,and there was no clinical manifestation of nerve function deficit after the procedure. All patients were followed up at (30±3) days after the procedure, and there were no adverse events. The modified Rankin scale score was 0. Echocardiography examination showed that the tranvalvular mean gradient was reduced from (63.0±19.2)mmHg(1 mmHg=0.133 kPa) on baseline to (18.1±4.9)mmHg(P<0.001), 4 cases had mild paravalvular leakage, and there was no moderate or severe paravalvular leakage.The NYHA classes was significantly improved at 30 days when compared with before the procedure(2 cases class Ⅱ, 4 cases class Ⅲ,3 cases class Ⅳ before the procedure,and 5 cases classⅠ, 4 cases class Ⅱ after the procedure, P=0.006) , and left ventricular ejection fraction increased from (55.9±13.1)% to (60.4±10.0)% (P=0.030).
Conclusion:Our initial experience indicates that transcarotid TAVR is safe and effective for patients with severe aortic valve stenosis.
